Logo image of KIN.BR

KINEPOLIS (KIN.BR) Stock Fundamental Analysis

EBR:KIN - Euronext Brussels - BE0974274061 - Common Stock - Currency: EUR

30.8  -1.2 (-3.75%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to KIN. KIN was compared to 43 industry peers in the Entertainment industry. KIN has a medium profitability rating, but doesn't score so well on its financial health evaluation. KIN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

KIN had positive earnings in the past year.
In the past year KIN had a positive cash flow from operations.
In multiple years KIN reported negative net income over the last 5 years.
KIN had a positive operating cash flow in 4 of the past 5 years.
KIN.BR Yearly Net Income VS EBIT VS OCF VS FCFKIN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

KIN has a Return On Assets of 3.54%. This is in the better half of the industry: KIN outperforms 69.77% of its industry peers.
Looking at the Return On Equity, with a value of 17.91%, KIN is in the better half of the industry, outperforming 72.09% of the companies in the same industry.
KIN has a Return On Invested Capital of 7.04%. This is in the better half of the industry: KIN outperforms 69.77% of its industry peers.
The Average Return On Invested Capital over the past 3 years for KIN is below the industry average of 9.53%.
The last Return On Invested Capital (7.04%) for KIN is above the 3 year average (6.76%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.54%
ROE 17.91%
ROIC 7.04%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
KIN.BR Yearly ROA, ROE, ROICKIN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

KIN has a better Profit Margin (7.00%) than 67.44% of its industry peers.
KIN's Profit Margin has declined in the last couple of years.
KIN's Operating Margin of 14.20% is amongst the best of the industry. KIN outperforms 81.40% of its industry peers.
In the last couple of years the Operating Margin of KIN has declined.
KIN has a worse Gross Margin (24.01%) than 88.37% of its industry peers.
KIN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.2%
PM (TTM) 7%
GM 24.01%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
KIN.BR Yearly Profit, Operating, Gross MarginsKIN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

2

2. Health

2.1 Basic Checks

KIN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
KIN has about the same amout of shares outstanding than it did 1 year ago.
KIN has more shares outstanding than it did 5 years ago.
KIN has a better debt/assets ratio than last year.
KIN.BR Yearly Shares OutstandingKIN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
KIN.BR Yearly Total Debt VS Total AssetsKIN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.45, we must say that KIN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.45, KIN is in the better half of the industry, outperforming 60.47% of the companies in the same industry.
KIN has a debt to FCF ratio of 6.27. This is a slightly negative value and a sign of low solvency as KIN would need 6.27 years to pay back of all of its debts.
KIN has a Debt to FCF ratio (6.27) which is comparable to the rest of the industry.
KIN has a Debt/Equity ratio of 2.70. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.70, KIN is doing worse than 72.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.7
Debt/FCF 6.27
Altman-Z 1.45
ROIC/WACC1.35
WACC5.22%
KIN.BR Yearly LT Debt VS Equity VS FCFKIN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.52 indicates that KIN may have some problems paying its short term obligations.
KIN's Current ratio of 0.52 is on the low side compared to the rest of the industry. KIN is outperformed by 76.74% of its industry peers.
A Quick Ratio of 0.49 indicates that KIN may have some problems paying its short term obligations.
KIN has a worse Quick ratio (0.49) than 76.74% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.49
KIN.BR Yearly Current Assets VS Current LiabilitesKIN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

4

3. Growth

3.1 Past

KIN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.79%.
The Earnings Per Share has been decreasing by -5.80% on average over the past years.
Looking at the last year, KIN shows a decrease in Revenue. The Revenue has decreased by -4.51% in the last year.
Measured over the past years, KIN shows a small growth in Revenue. The Revenue has been growing by 0.95% on average per year.
EPS 1Y (TTM)-27.79%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%15.09%
Revenue 1Y (TTM)-4.51%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%4.74%

3.2 Future

KIN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.15% yearly.
Based on estimates for the next years, KIN will show a small growth in Revenue. The Revenue will grow by 4.98% on average per year.
EPS Next Y48.8%
EPS Next 2Y31.49%
EPS Next 3Y24.23%
EPS Next 5Y16.15%
Revenue Next Year8.34%
Revenue Next 2Y7.05%
Revenue Next 3Y6.07%
Revenue Next 5Y4.98%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KIN.BR Yearly Revenue VS EstimatesKIN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
KIN.BR Yearly EPS VS EstimatesKIN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2 3

5

4. Valuation

4.1 Price/Earnings Ratio

KIN is valuated rather expensively with a Price/Earnings ratio of 20.95.
Based on the Price/Earnings ratio, KIN is valued a bit cheaper than the industry average as 74.42% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.78, KIN is valued a bit cheaper.
KIN is valuated correctly with a Price/Forward Earnings ratio of 12.35.
KIN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. KIN is cheaper than 76.74% of the companies in the same industry.
KIN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.32.
Industry RankSector Rank
PE 20.95
Fwd PE 12.35
KIN.BR Price Earnings VS Forward Price EarningsKIN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KIN is on the same level as its industry peers.
79.07% of the companies in the same industry are more expensive than KIN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.97
EV/EBITDA 9.45
KIN.BR Per share dataKIN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as KIN's earnings are expected to grow with 24.23% in the coming years.
PEG (NY)0.43
PEG (5Y)N/A
EPS Next 2Y31.49%
EPS Next 3Y24.23%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.21%, KIN has a reasonable but not impressive dividend return.
The stock price of KIN dropped by -20.10% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
KIN's Dividend Yield is a higher than the industry average which is at 1.90.
With a Dividend Yield of 1.21, KIN pays less dividend than the S&P500 average, which is at 2.46.
Industry RankSector Rank
Dividend Yield 1.21%

5.2 History

The dividend of KIN decreases each year by -3.32%.
Dividend Growth(5Y)-3.32%
Div Incr Years1
Div Non Decr Years1
KIN.BR Yearly Dividends per shareKIN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

36.36% of the earnings are spent on dividend by KIN. This is a low number and sustainable payout ratio.
DP36.36%
EPS Next 2Y31.49%
EPS Next 3Y24.23%
KIN.BR Yearly Income VS Free CF VS DividendKIN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
KIN.BR Dividend Payout.KIN.BR Dividend Payout, showing the Payout Ratio.KIN.BR Dividend Payout.PayoutRetained Earnings

KINEPOLIS

EBR:KIN (4/28/2025, 5:28:19 PM)

30.8

-1.2 (-3.75%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)08-21 2025-08-21
Inst Owners19.91%
Inst Owner ChangeN/A
Ins Owners1.8%
Ins Owner ChangeN/A
Market Cap843.00M
Analysts86
Price Target51.68 (67.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.21%
Yearly Dividend0.54
Dividend Growth(5Y)-3.32%
DP36.36%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.71%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.16%
EPS NY rev (3m)-8.24%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-2.82%
Valuation
Industry RankSector Rank
PE 20.95
Fwd PE 12.35
P/S 1.46
P/FCF 6.97
P/OCF 5.15
P/B 3.73
P/tB 21.63
EV/EBITDA 9.45
EPS(TTM)1.47
EY4.77%
EPS(NY)2.49
Fwd EY8.1%
FCF(TTM)4.42
FCFY14.36%
OCF(TTM)5.98
OCFY19.41%
SpS21.12
BVpS8.25
TBVpS1.42
PEG (NY)0.43
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.54%
ROE 17.91%
ROCE 9.58%
ROIC 7.04%
ROICexc 7.81%
ROICexgc 10.3%
OM 14.2%
PM (TTM) 7%
GM 24.01%
FCFM 20.93%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
ROICexc(3y)7.02%
ROICexc(5y)N/A
ROICexgc(3y)8.91%
ROICexgc(5y)N/A
ROCE(3y)9.19%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-1%
ROICexc growth 3YN/A
ROICexc growth 5Y-1.69%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
F-Score5
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 2.7
Debt/FCF 6.27
Debt/EBITDA 3.71
Cap/Depr 52.05%
Cap/Sales 7.37%
Interest Coverage 3.53
Cash Conversion 99.8%
Profit Quality 299.1%
Current Ratio 0.52
Quick Ratio 0.49
Altman-Z 1.45
F-Score5
WACC5.22%
ROIC/WACC1.35
Cap/Depr(3y)43.12%
Cap/Depr(5y)41.32%
Cap/Sales(3y)6.29%
Cap/Sales(5y)10.19%
Profit Quality(3y)301.12%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.79%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%15.09%
EPS Next Y48.8%
EPS Next 2Y31.49%
EPS Next 3Y24.23%
EPS Next 5Y16.15%
Revenue 1Y (TTM)-4.51%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%4.74%
Revenue Next Year8.34%
Revenue Next 2Y7.05%
Revenue Next 3Y6.07%
Revenue Next 5Y4.98%
EBIT growth 1Y-22.5%
EBIT growth 3YN/A
EBIT growth 5Y-3.89%
EBIT Next Year128.32%
EBIT Next 3Y37.96%
EBIT Next 5Y22.36%
FCF growth 1Y2.2%
FCF growth 3Y19%
FCF growth 5Y6.53%
OCF growth 1Y5.96%
OCF growth 3Y22.57%
OCF growth 5Y1.63%